Drug intelligence / Profile preview

lapis judaicus

Development stage
Phase 2
Modality
Small Molecules
Administration
Oral
01

Overview

Lapis Judaicus is a mineral drug traditionally used in Unani and Ayurvedic systems of medicine, primarily for the management of urolithiasis (kidney and bladder stones) and other urinary disorders. It is composed mainly of fossilized sea urchin spines containing minerals such as calcium, magnesium, silicon, aluminum oxide, hematite (iron oxide), and silica[1][2][4]. The drug has been described since Roman times by figures such as Dioscorides and Galen. In traditional practice, it is administered either by sucking the stone or consuming its powdered form mixed with liquids[2]. Lapis Judaicus exhibits diuretic (Mudirr-e-Baul) and lithotriptic (Mufattit-e-Hasat) properties—meaning it promotes urine flow and helps dissolve urinary stones[4]. Clinical studies suggest that it can reduce the size of renal calculi without significant adverse effects on kidney or liver function[5]. However, robust clinical evidence remains limited; most data come from small-scale trials or traditional use reports. It continues to be used in folk medicine across Iran, Pakistan, Afghanistan, India—and occasionally as an ingredient in multi-herbal formulations.

Other names
Hajrul yahoodHajar ul YahoodJew's Stone

Beyond the preview

Go deeper on lapis judaicus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lapis judaicus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call